Skip to main content
. 2021 Feb 18;15(6):938–949. doi: 10.1093/ecco-jcc/jjab023

Figure 3.

Figure 3.

Proportion [90% CI] of patients in the long-term efficacy set* with endoscopic mucosal healing at baseline [Week 12 of TURANDOT], Week 16, and Weeks 40–72 of TURANDOT II. 90% CIs calculated using Wilson score test. Treatment groups based on initial randomisation assignment. CI, confidence interval. *The long-term efficacy set was defined as the subgroup of patients who had a second endoscopy between Week 40 and Week 72.